CCL23 is a potent chemoattractant for myeloid cells that stimulates chemotactic migration of endothelial cells to support tumor angiogenesis in ovarian tumors and increases the proportion of exhausted CD8+ T-cells in the TME [12,13,14]. The gene discussed is CCL23; the disease is neoplasm.